388 related articles for article (PubMed ID: 28599250)
21. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.
Klein U; Lia M; Crespo M; Siegel R; Shen Q; Mo T; Ambesi-Impiombato A; Califano A; Migliazza A; Bhagat G; Dalla-Favera R
Cancer Cell; 2010 Jan; 17(1):28-40. PubMed ID: 20060366
[TBL] [Abstract][Full Text] [Related]
22. Monoallelic and biallelic deletions of 13q14.3 in chronic lymphocytic leukemia: FISH vs miRNA RT-qPCR detection.
Smonskey MT; Block AW; Deeb G; Chanan-Khan AA; Bernstein ZP; Miller KC; Wallace PK; Starostik P
Am J Clin Pathol; 2012 Apr; 137(4):641-6. PubMed ID: 22431542
[TBL] [Abstract][Full Text] [Related]
23. Role of microRNAs in regulation of the TNF/TNFR gene superfamily in chronic lymphocytic leukemia.
Srivastava S; Tsongalis GJ; Kaur P
Clin Biochem; 2016 Nov; 49(16-17):1307-1310. PubMed ID: 27544753
[TBL] [Abstract][Full Text] [Related]
24. Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity.
Salerno E; Scaglione BJ; Coffman FD; Brown BD; Baccarini A; Fernandes H; Marti G; Raveche ES
Mol Cancer Ther; 2009 Sep; 8(9):2684-92. PubMed ID: 19723889
[TBL] [Abstract][Full Text] [Related]
25. Investigation of 13q14.3 deletion by cytogenetic analysis and FISH technique and miRNA-15a and miRNA-16-1 by real time PCR in chronic lymphocytic leukemia.
Yılmaz M; Kuru RD; Erdoğan I; Soysal T; Hacıhanefioglu S; Baykara O
Afr Health Sci; 2022 Sep; 22(3):173-182. PubMed ID: 36910369
[TBL] [Abstract][Full Text] [Related]
26. The role of the genetic abnormalities, epigenetic and microRNA in the prognosis of chronic lymphocytic leukemia.
Tari K; Shamsi Z; Reza Ghafari H; Atashi A; Shahjahani M; Abroun S
Exp Oncol; 2018 Dec; 40(4):261-267. PubMed ID: 30593759
[TBL] [Abstract][Full Text] [Related]
27. The Role of miR-15a and miR-16-1 in the Pathogenesis of Chronic Lymphocytic Leukemia, and the Importance of microRNAs in Targeted Therapies.
Calva-Lopez A; Tirado CA
J Assoc Genet Technol; 2018; 44(3):84-87. PubMed ID: 30208014
[TBL] [Abstract][Full Text] [Related]
28. Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
Zhu DX; Miao KR; Fang C; Fan L; Zhu W; Zhu HY; Zhuang Y; Hong M; Liu P; Xu W; Li JY
Leuk Res; 2011 Jun; 35(6):730-4. PubMed ID: 21130495
[TBL] [Abstract][Full Text] [Related]
29. Differential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemia.
Papakonstantinou N; Ntoufa S; Chartomatsidou E; Papadopoulos G; Hatzigeorgiou A; Anagnostopoulos A; Chlichlia K; Ghia P; Muzio M; Belessi C; Stamatopoulos K
Mol Med; 2013 May; 19(1):115-23. PubMed ID: 23615967
[TBL] [Abstract][Full Text] [Related]
30. Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia.
Sampath D; Liu C; Vasan K; Sulda M; Puduvalli VK; Wierda WG; Keating MJ
Blood; 2012 Feb; 119(5):1162-72. PubMed ID: 22096249
[TBL] [Abstract][Full Text] [Related]
31. Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia.
Rossi M; Fuligni F; Ciccone M; Agostinelli C; Righi S; Luciani M; Laginestra MA; Rigolin GM; Sapienza MR; Gazzola A; Mannu C; Cuneo A; Pileri S; Piccaluga PP
Biomed Res Int; 2013; 2013():715391. PubMed ID: 24392455
[TBL] [Abstract][Full Text] [Related]
32. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
[TBL] [Abstract][Full Text] [Related]
33. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.
Mirzaei H; Fathullahzadeh S; Khanmohammadi R; Darijani M; Momeni F; Masoudifar A; Goodarzi M; Mardanshah O; Stenvang J; Jaafari MR; Mirzaei HR
J Cell Physiol; 2018 Feb; 233(2):888-900. PubMed ID: 28084621
[TBL] [Abstract][Full Text] [Related]
34. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.
Pekarsky Y; Santanam U; Cimmino A; Palamarchuk A; Efanov A; Maximov V; Volinia S; Alder H; Liu CG; Rassenti L; Calin GA; Hagan JP; Kipps T; Croce CM
Cancer Res; 2006 Dec; 66(24):11590-3. PubMed ID: 17178851
[TBL] [Abstract][Full Text] [Related]
35. Role of microRNAs in Chronic Lymphocytic Leukemia Pathogenesis.
Javandoost E; Firoozi-Majd E; Rostamian H; Khakpoor-Koosheh M; Mirzaei HR
Curr Med Chem; 2020; 27(2):282-297. PubMed ID: 31544709
[TBL] [Abstract][Full Text] [Related]
36. Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic Leukemia.
Stamatopoulos B; Van Damme M; Crompot E; Dessars B; Housni HE; Mineur P; Meuleman N; Bron D; Lagneaux L
Mol Med; 2015 Jan; 21(1):123-33. PubMed ID: 25584781
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic Value of Plasma miR-145 and miR-185 as Targeting of the APRIL Oncogene in the B-cell Chronic Lymphocytic Leukemia.
Bagheri M; Khansarinejad B; Mosayebi G; Moradabadi A; Mondanizadeh M
Asian Pac J Cancer Prev; 2021 Jan; 22(1):111-117. PubMed ID: 33507687
[TBL] [Abstract][Full Text] [Related]
38. Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212.
Tavolaro S; Colombo T; Chiaretti S; Peragine N; Fulci V; Ricciardi MR; Messina M; Bonina S; Brugnoletti F; Marinelli M; Di Maio V; Mauro FR; Del Giudice I; Macino G; Foà R; Guarini A
Genes Chromosomes Cancer; 2015 Apr; 54(4):222-34. PubMed ID: 25645730
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia.
Ferrajoli A; Shanafelt TD; Ivan C; Shimizu M; Rabe KG; Nouraee N; Ikuo M; Ghosh AK; Lerner S; Rassenti LZ; Xiao L; Hu J; Reuben JM; Calin S; You MJ; Manning JT; Wierda WG; Estrov Z; O'Brien S; Kipps TJ; Keating MJ; Kay NE; Calin GA
Blood; 2013 Sep; 122(11):1891-9. PubMed ID: 23821659
[TBL] [Abstract][Full Text] [Related]
40. TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia.
Balatti V; Rizzotto L; Miller C; Palamarchuk A; Fadda P; Pandolfo R; Rassenti LZ; Hertlein E; Ruppert AS; Lozanski A; Lozanski G; Kipps TJ; Byrd JC; Croce CM; Pekarsky Y
Proc Natl Acad Sci U S A; 2015 Feb; 112(7):2169-74. PubMed ID: 25646413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
